Results 121 to 130 of about 19,943,678 (222)

Harnessing Terminalia arjuna in Next Generation Phytomedicine: Cutting Edge Nutraceutical Trends Shaping Food and Health

Food Science &Nutrition, Volume 14, Issue 10, October 2026.
This graphical abstract illustrates the complete translational pipeline of Terminalia arjuna in modern phytomedicine and functional food development. It is rich in key bioactive compounds like arjunolic acid, arjungenin, flavonoids, and tannins which serve as the foundation for the plant's versatile medicinal uses and offers broad therapeutic benefits ...
Ishani Banerjee, Fahika Nazeerulla, Manash Kumar Paul, Sujit Kumar Bhutia, Deblina Basu, Subhadip Mukhopadhyay   +5 more
wiley   +1 more source

Association Between Temperature Management Using Passive Thermal Insulation and a Modified Aldrete Score During Cryoablation of Paroxysmal Atrial Fibrillation Under General Anesthesia

Journal of Arrhythmia, Volume 42, Issue 5, October 2026.
This study demonstrated that the Δ in core temperature was significantly lower in the Blanket (blue bar) group than in the Control (red bar) group and the passive thermal insulation using heat insulation blankets significantly decreased the rate of hypothermia‐induced unsuccessful early recovery from general anesthesia from 64% to 37%.
Arisa Yamaguchi, Masao Takemoto, Takuya Nagata, Reimi Goya, Yoshie Sadasue, Kaori Nagaoka, Norie Terauchi, Hijiri Inoue, Takahiro Mito, Michiko Kurachi, Takuya Tsuchihashi, Kyoko Matsuno, Tetsuji Okamoto   +12 more
wiley   +1 more source

Comparative efficacy and safety of the non-vitamin K antagonist oral anticoagulants for patients with nonvalvular atrial fibrillation

, 2015
The non-vitamin K antagonist oral anticoagulants (NOACs), such as the thrombin inhibitor (dabigatran) and the direct factor Xa inhibitors (rivaroxaban, apixaban, and edoxaban), have been shown to be at least as efficacious and safe as conventional oral ...
Senoo, Keitaro, Lip, Gregory Y H
core   +1 more source

Transplantation of Elderly Human Gut Microbiota Into Pigs Reprograms Intestinal Barrier Function, Plasma Metabolome, and Gut Mucosal Transcriptomic Landscape

Aging Cell, Volume 25, Issue 10, October 2026.
Elderly human donor microbiota disrupts intestinal barrier integrity and reshapes host metabolic and mucosal transcriptional profiles in human microbiota‐associated pigs. Integrated multi‐omics analyses identify coordinated microbial, metabolic, and host alterations associated with age‐related intestinal decline.
Jiaxin Wang, Lingyu Li, Lihua Mei, Zhining Tang, Baorui Liao, Qianye Zhao, Yuzeng Wang, Qingyao Fu, Liu Ren, Zhian Zhai, Yifei Xu, Aoyu Yang, Shuai Duan, Zhengyuan Zhai, Yanling Hao, Yalin Zhou, Yajun Xu, Ying Yang, Zhenlong Wu, Yun Ji   +19 more
wiley   +1 more source

Proper dosing and key drug interactions of the non-vitamin K antagonist oral anticoagulants. Summary from the 2024 European Society of Cardiology (ESC) Guidelines

Cardiologia Hungarica
The use of non-vitamin K antagonist oral anticoagulants (NOACs) has become a cornerstone of stroke prevention in patients with atrial fibrillation. This brief summary, based on the latest European guidelines, aims to summarize the appropriate dosing ...
Letícia Kazareczki, Máté Vámos
doaj   +1 more source

Design and Implementation of an Automated Interpretation Algorithm for Lupus Anticoagulant Functional Testing

International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 1181-1188, October 2026.
ABSTRACT Introduction Lupus anticoagulant (LA) testing is essential, albeit complex, in the laboratory diagnosis of antiphospholipid syndrome (APS). Given the multi‐step workflow and the variability introduced by anticoagulant therapy, reagent differences, and interpretive approaches, result interpretation requires expert evaluation.
Chiara Novelli, Arianna Gatti, Flora Ierna, Elena Riccardi, Irene Cuppari   +4 more
wiley   +1 more source

Non-Vitamin K Antagonist Oral Anticoagulants [PDF]

, 2016
Eduard Shantsila, Gregory YH Lip
openaire   +1 more source

Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation and valvular heart disease : systematic review and meta-analysis

, 2017
Published on behalf of the European Society of Cardiology. All rights reserved. ©The Author 2017The non-vitamin K antagonist oral anticoagulants (NOACs) were approved for non-valvular atrial fibrillation (AF) but this term may be misnomer. Thus, the term
Joaquim J Ferreira, Ferreira, Joaquim J, João Costa, David, Cláudio, Costa, João, Caldeira, Daniel, Pinto, Fausto J., Daniel Caldeira, Cláudio David, Fausto J Pinto   +9 more
core   +1 more source

How I Investigate Borderline Prolonged aPTT: An Integrated Laboratory Approach to Mixing Studies and Factor Analysis

International Journal of Laboratory Hematology, Volume 48, Issue 5, Page 951-960, October 2026.
ABSTRACT Borderline prolongation of routine clotting assays—particularly the activated partial thromboplastin time (aPTT)—is a common interpretative challenge in laboratory hematology. These reproducible but mildly prolonged results often lie just beyond the upper reference limit and can trigger unnecessary follow‐up, delays, or misinterpretation ...
Nikolaos Androulakis, Eleni Nioti, Antonios Dilintas, Christina Kalpadakis   +3 more
wiley   +1 more source

Non-vitamin K oral anticoagulant use in the elderly: a prospective real-world study – data from the REGIstry of patients on Non-vitamin K oral Anticoagulants (REGINA)

, 2019
Mauro Monelli, Mauro Molteni, Giuseppina Cassetti, Laura Bagnara, Valeria De Grazia, Lorenza Zingale, Franca Zilli, Maurizio Bussotti, Paolo Totaro, Beatrice De Maria, Laura Adelaide Dalla Vecchia Cardiac Rehabilitation Department, IRCCS Istituti Clinici
Totaro P, Zilli F, Cassetti G, Dalla Vecchia LA, Bussotti M, Zingale L, De Maria B, Monelli M, Molteni M, De Grazia V, Bagnara L   +10 more
core